Posterior vitreous detachment induced by nattokinase (Subtilisin NAT): A novel enzyme for pharmacologic vitreolysis

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 5, 2006, Pages 2075-2079

  Takano, Akiomi ^a   Hirata, Akira ^a   Ogasawara, Kazuya ^b   Sagara, Nina ^a   Inomata, Yasuya ^a   Kawaji, Takahiro ^a   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Japan Bio Sci Laboratory Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NATTOKINASE; SERINE PROTEINASE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; SUBTILISIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; ELECTRORETINOGRAPHY; HISTOLOGY; MICROSCOPY; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; RABBIT; SCANNING ELECTRON MICROSCOPY; VITREOUS BODY DETACHMENT; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; INJECTION; PATHOLOGY; PHYSIOLOGY; RETINA; ULTRASTRUCTURE; VITREOUS BODY;

ANIMALS; ELECTRORETINOGRAPHY; INJECTIONS; MICROSCOPY, ELECTRON, SCANNING; RABBITS; RETINA; SUBTILISINS; VITREOUS BODY; VITREOUS DETACHMENT;

EID: 33744742897     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0130     Document Type: Article

References (25)

1. Sebag J. Macromolecular structure of vitreous. Prog Polym Sci. 1998;23:415-446.
2. Sebag J. Pharmacologic vitreolysis. Retina. 1998;18:1-3.
3. Trese MT. Enzymatic vitreous surgery. Semin Ophthalmol. 2000;15:116-121.
4. Tanaka M, Qui H. Pharmacological vitrectomy. Semin Ophthalmol. 2000;15:51-61.
5. Sebag J. Is pharmacologic vitreolysis brewing? Retina. 2002;22:1-3.
6. Gottlieb JL, Antoszyk AN, Hatchell DL, Saloupis P. The safety of intravitreal hyaluronidase: a clinical and histologic study. Invest Ophthalmol Vis Sci. 1990;31:2345-2352.
7. Harooni M, McMillan T, Refojo M. Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase. Retina. 1998;18:16 -22.
8. Verstraeten TC, Chapman C, Hartzer M, et al. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol. 1993;111:849-854.
9. Hikichi T, Yanagiya N, Kado M, et al. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina. 1999;19:55-58.
10. Gandorfer A, Putz E, Welge-Lussen U, et al. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol. 2001;85:6 -10.
11. Kim NJ, Yu HG, Yu YS, Chung H. Long-term effect of plasmin on the vitreolysis in rabbit eyes. Korean J Ophthalmol. 2004;18:35-40.
12. Wang F, Wang Z, Sun X, et al. Safety and efficacy of dispase and plasmin in pharmacologic vitreolysis. Invest Ophthalmol Vis Sci. 2004;45:3286-3290.
13. Gandorfer A, Priglinger S, Schebitz K, et al. Vitreoretinal morphology of plasmin-treated human eyes. Am J Ophthalmol. 2002;133:156-159.
14. Li X, Shi X, Fan J. Posterior vitreous detachment with plasmin in the isolated human eye. Graefes Arch Clin Exp Ophthalmol. 2002;240:56-62.
15. Margherio AR, Margherio RR, Hartzer M, et al. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology. 1998;105:1617-1620.
16. Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmology. 2000;107:1607-1611.
17. Williams JG, Trese MT, Williams GA, Hartzer MK. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology 2001;108:1902-1905; discussion 1905-1906.
18. Azzolini C, D'Angelo A, Maestranzi G, et al. Intrasurgical plasmin enzyme in diabetic macular edema. Am J Ophthalmol. 2004;138:560-566.
19. Nakamura T, Yamagata Y, Ichishima E. Nucleotide sequence of the subtilisin NAT gene, aprN, of Bacillus subtilis (natto). Biosci Biotechnol Biochem. 1992;56:1869-1871.
20. Sumi H, Hamada H, Tsushima H, et al. A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet. Experientia. 1987;43:1110-1111.
21. Sumi H, Hamada H, Nakanishi K, Hiratani H. Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase. Acta Haematol. 1990;84:139-143.
22. Urano T, Ihara H, Umemura K, et al. The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis cleaves and inactivates plasminogen activator inhibitor type 1. J Biol Chem. 2001;276:24690-24696.
23. Hikichi T, Kado M, Yoshida A. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit. Retina. 2000;20:195-198.
24. Wang ZL, Zhang X, Xu X, et al. PVD following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy. Retina. 2005;25:38-43.
25. Takano A, Hirata A, Inomata Y, et al. Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous. Am J Ophthalmol. 2005;140:654-660.